“Biomarker-Guided Oncology Practice in Non–Small Cell Lung Cancer: Utilization Patterns, Turnaround Time, and Sector-Associated Access Barriers”, J Precis Med Health Res, vol. 2, no. 2, p. e20, Dec. 2025, doi: 10.61919/p8kycn81.